hx008
Showing 1 - 9 of 9
Metastatic Colorectal Cancer Trial in China (HX008, Investigator's Choice Chemotherapy)
Not yet recruiting
- Metastatic Colorectal Cancer
- HX008
- Investigator's Choice Chemotherapy
-
Hefei, Anhui, China
- +9 more
Dec 8, 2022
Advanced Solid Tumor Trial in Changsha, Wuhan (HX008)
Recruiting
- Advanced Solid Tumor
- HX008
-
Changsha, China
- +2 more
Mar 28, 2021
Bladder Cancer Trial in China (HX008)
Recruiting
- Bladder Cancer
- HX008
-
Wuhan, Hubei, China
- +4 more
Jan 31, 2021
Melanoma Trial in China (HX008)
Active, not recruiting
- Melanoma
- HX008
-
Beijing, Beijing, China
- +10 more
Feb 7, 2021
Nonsquamous NSCLC Trial in China (HX008, Pembrolizumab, pemetrexed)
Recruiting
- Nonsquamous Non-small Cell Lung Cancer
- HX008
- +3 more
-
Hefei, Anhui, China
- +9 more
Feb 7, 2021
Anaplastic Thyroid Cancer Trial in Beijing (HX008)
Not yet recruiting
- Anaplastic Thyroid Cancer
- HX008
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Oct 2, 2020
Hepatocellular Carcinoma Trial in China (HX008, Bevacizumab, Lenvatinib)
Recruiting
- Hepatocellular Carcinoma
- HX008
- +2 more
-
Hefei, Anhui, China
- +12 more
Feb 2, 2021
Stomach Cancer Trial in China (Irinotecan Hydrochloride Injection, HX008, Placebo)
Recruiting
- Stomach Cancer
- Irinotecan Hydrochloride Injection
- +2 more
-
Hefei, Anhui, China
- +63 more
Jan 26, 2021